FORM OF SUPPORT AGREEMENTSupport Agreement • April 18th, 2017 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of [·], 2017, is by and between Alpine Immune Sciences, Inc., a Delaware corporation (the “Company”), and the Person set forth on Schedule A (the “Stockholder”).
FORM OF SUPPORT AGREEMENTSupport Agreement • April 18th, 2017 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of [•], 2017, is by and between Nivalis Therapeutics, Inc., a Delaware corporation (the “Company”), and the Persons set forth on Schedule A (each such Person a “Stockholder” and collectively the “Stockholders”).
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: NIVALIS THERAPEUTICS, INC., a Delaware corporation; NAUTILUS MERGER SUB, INC., a Delaware corporation; and ALPINE IMMUNE SCIENCES, INC., a Delaware corporation Dated as of April 18, 2017Merger Agreement • April 18th, 2017 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made and entered into as of April 18, 2017, by and among NIVALIS THERAPEUTICS, INC., a Delaware corporation (“Nautilus”), NAUTILUS MERGER SUB, INC., a Delaware corporation and wholly owned subsidiary of Nautilus (“Merger Sub”), and ALPINE IMMUNE SCIENCES, INC., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
